Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


19.07.2021

2 Antimicrob Agents Chemother
1 Clin Infect Dis
1 PLoS Med
7 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. ERNEST JP, Sarathy J, Wang N, Kaya F, et al
    Lesion penetration and activity limit the utility of second-line injectable agents in pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0050621. doi: 10.1128/AAC.00506.
    PubMed         Abstract available

  2. GEWITZ AD, Solans BP, Mac Kenzie WR, Heilig C, et al
    A Longitudinal Model-Based Biomarker Analysis of Exposure Response in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0179420. doi: 10.1128/AAC.01794.
    PubMed         Abstract available


    Clin Infect Dis

  3. WEIR IR, Wasserman S
    Treatment effect measures for culture conversion endpoints in phase IIb tuberculosis treatment trials.
    Clin Infect Dis. 2021 Jul 13. pii: 6319902. doi: 10.1093.
    PubMed         Abstract available


    PLoS Med

  4. YU S, Sohn H, Kim HY, Kim H, et al
    Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    PLoS Med. 2021;18:e1003717.
    PubMed         Abstract available


    PLoS One

  5. SAMUELS THA, Wyss R, Ongarello S, Moore DAJ, et al
    Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    PLoS One. 2021;16:e0254002.
    PubMed         Abstract available

  6. BOAH M, Kpordoxah MR, Adokiya MN
    Self-reported gender differentials in the knowledge of tuberculosis transmission and curative possibility using national representative data in Ghana.
    PLoS One. 2021;16:e0254499.
    PubMed         Abstract available

  7. SHAYO FK, Shayo SC
    Readiness of healthcare facilities with tuberculosis services to manage diabetes mellitus in Tanzania: A nationwide analysis for evidence-informed policy-making in high burden settings.
    PLoS One. 2021;16:e0254349.
    PubMed         Abstract available

  8. MAOKOLA WM, Ngowi BJ, Mahande MJ, Todd J, et al
    Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
    PLoS One. 2021;16:e0254082.
    PubMed         Abstract available

  9. TANG J, Huang Y, Cai Z, Ma Y, et al
    Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0254571.
    PubMed         Abstract available

  10. TADOKERA R, Huo S, Theron G, Timire C, et al
    Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
    PLoS One. 2021;16:e0254204.
    PubMed         Abstract available

  11. TAYE H, Alemu K, Mihret A, Ayalew S, et al
    Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
    PLoS One. 2021;16:e0253480.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: